Blair William & CO Charles River Laboratories International, Inc. Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Blair William & CO holds 3,427 shares of CRL stock, worth $747,908. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,427

Previous 3,464 1.07%

Holding current value

$747,908

Previous $818,000 13.45%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$203.52 - $273.43 $7,530 - $10,116	-37 Reduced 1.07%	3,427 $928,000
Q4 2023 Feb 12, 2024	SELL	$164.52 - $238.84 $22,703 - $32,959	-138 Reduced 3.83%	3,464 $818,000
Q3 2023 Nov 09, 2023	SELL	$194.44 - $217.61 $63,387 - $70,940	-326 Reduced 8.3%	3,602 $705,000
Q2 2023 Aug 11, 2023	SELL	$183.71 - $210.25 $31,965 - $36,583	-174 Reduced 4.24%	3,928 $825,000
Q1 2023 May 12, 2023	SELL	$191.89 - $259.92 $192,273 - $260,439	-1,002 Reduced 19.63%	4,102 $827,000

Q4 2022 Feb 10, 2023	BUY	$197.11 - $250.07 $41,984 - $53,264	213 Added 4.35%	5,104 $1.11 Million
Q3 2022 Nov 09, 2022	SELL	$182.44 - $250.54 $264,355 - $363,032	-1,449 Reduced 22.85%	4,891 $963,000
Q2 2022 Aug 10, 2022	SELL	$204.13 - $302.4 $680,569 - $1.01 Million	-3,334 Reduced 34.46%	6,340 $1.36 Million
Q1 2022 May 13, 2022	SELL	$255.51 - $362.11 $140,530 - $199,160	-550 Reduced 5.38%	9,674 $2.75 Million
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $1.76 Million - $2.25 Million	-5,012 Reduced 32.9%	10,224 $3.85 Million
Q3 2021 Nov 12, 2021	BUY	$372.64 - $458.3 $43,226 - $53,162	116 Added 0.77%	15,236 $6.29 Million
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $48,538 - $61,322	-165 Reduced 1.08%	15,120 $5.59 Million
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $1.39 Million - $1.66 Million	5,552 Added 57.04%	15,285 $4.43 Million
Q4 2020 Feb 09, 2021	BUY	$222.0 - $252.62 $931,956 - $1.06 Million	4,198 Added 75.84%	9,733 $2.43 Million
Q3 2020 Nov 06, 2020	BUY	$175.56 - $226.45 $13,342 - $17,210	76 Added 1.39%	5,535 $1.25 Million
Q2 2020 Aug 12, 2020	BUY	$118.84 - $189.72 $33,750 - $53,880	284 Added 5.49%	5,459 $952,000
Q1 2020 May 11, 2020	BUY	$98.9 - $178.34 $3,263 - $5,885	33 Added 0.64%	5,175 $653,000
Q4 2019 Feb 13, 2020	BUY	$126.05 - $152.76 $648,149 - $785,491	5,142 New	5,142 $785,000
Q3 2018 Nov 13, 2018	SELL	$112.11 - $134.54 $311,553 - $373,886	-2,779 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$102.37 - $117.25 $4,401 - $5,041	-43 Reduced 1.52%	2,779 $312,000
Q1 2018 May 15, 2018	BUY	$98.19 - $115.2 $81,399 - $95,500	829 Added 41.6%	2,822 $301,000
Q4 2017 Feb 14, 2018	BUY	$100.43 - $118.09 $200,156 - $235,353	1,993	1,993 $218,000

Others Institutions Holding CRL

# of Institutions

728

Shares Held

51.3M

Call Options Held

183K

Put Options Held

346K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $11.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account